RecruitingNCT04494295

The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation

Sponsor

Integra LifeSciences Corporation

Enrollment

500 participants

Start Date

Oct 23, 2020

Study Type

OBSERVATIONAL

Conditions

Supratentorial Hemorrhage

Summary

This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Aurora Surgiscope System for people with supratentorial hemorrhage. The study is currently recruiting participants at 20 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAurora Surgiscope System

MIS evacuation of hematoma using the Aurora Surgiscope System

Locations(20)

Providence Health

Burbank, California, United States

University of Miami

Miami, Florida, United States

University of South Florida

Tampa, Florida, United States

Rush University Medical Center

Chicago, Illinois, United States

MedStar Health Research Institute

Baltimore, Maryland, United States

Corewell Health

Grand Rapids, Michigan, United States

University of Missouri

Columbia, Missouri, United States

Washington University in St. Louis

St Louis, Missouri, United States

JFK university

Edison, New Jersey, United States

University at Buffalo

Buffalo, New York, United States

Icahn School of Medicine at Mount Sinai

New York, New York, United States

University of North Carolina

Chapel Hill, North Carolina, United States

Cleveland Clinic

Cleveland, Ohio, United States

University of Oklahoma

Oklahoma City, Oklahoma, United States

Pennsylvania State University

Hershey, Pennsylvania, United States

University of Pennsylvania

Philadelphia, Pennsylvania, United States

Prisma Health - Upstate

Greenville, South Carolina, United States

UT Health

Houston, Texas, United States

University of Utah

Salt Lake City, Utah, United States

University of Washington - Harborview

Seattle, Washington, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04494295